HHS is backing two new pathogen reduction technologies to reduce the risk of the transmission of diseases like Zika via blood product transfusions. The Cerus Corporation of Concord, Calif., will ...
CONCORD, Calif.--(BUSINESS WIRE)--Cerus Corporation (Nasdaq: CERS) announced today the CE mark approval of its next-generation LED-based illumination device, or the INT200, for the INTERCEPT Blood ...
CONCORD, Calif.--(BUSINESS WIRE)--Cerus Corporation (Nasdaq: CERS) announced today two in-country regulatory approvals for INT200, one by the French National Agency for Medicines and Health Product ...
CONCORD, Calif.--(BUSINESS WIRE)-- Cerus Corporation (CERS) announced today that it has entered into a group purchasing agreement with Blood Centers of America (BCA), the largest blood supply ...
Cerus Corporation (Nasdaq: CERS) announced today the signing of a new, four-year supply agreement with Établissement Français du Sang (EFS), the French Blood Establishment, for the INTERCEPT Blood ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results